Maximus vs MEDVi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MEDVi beats Maximus overall, scoring 7.7/10 vs 7.1/10. MEDVi is more affordable at $299/mo vs $300/mo. Choose Maximus for men who want glp-1 alongside testosterone or other men's hea. Choose MEDVi for users who want a low entry price with oral and injectable co.
A side-by-side comparison of Maximus and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
Maximus
#38 of 40Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.
Visit MaximusMEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | Maximus | MEDVi |
|---|---|---|
| Our Score | 7.1/10 | 7.7/10 |
| Starting Price | $300/mo | $299/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Men who want GLP-1 alongside testosterone or other men's health protocols | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #38 | #21 |
Pros & Cons Compared
Maximus
Pros
- +Lowest entry price in the market — $79.99/mo microdose semaglutide, $99.99/mo 3-month starter pack
- +GLP-1 microdosing available for BMI as low as 22 — the only platform serving patients below standard obesity criteria
- +Nausea-reducing formula with added glycine and B12 to ease GLP-1 side effects
- +Free expedited shipping on all medication orders
Cons
- −Deceptive pricing structure — $99.99/mo is intro only, standard dosing is $299.99/mo with separate $28-35 consultation fees and $199-349/yr lab costs
- −Refuses to disclose compounding pharmacy partners — a transparency red flag for a healthcare platform
- −Prices increase as dose escalates on bulk plans — unpredictable total cost over time
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MEDVi edges out Maximus with a score of 7.7/10 vs 7.1/10. If budget is your priority, MEDVi starts at $299/mo compared to Maximus's $300/mo. Choose Maximus if you want: men who want glp-1 alongside testosterone or other men's health protocols. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.